West Pharmaceutical Services, Inc. (WST) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $327.90 -0.02%
EPS Growth %: +13.0%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.0%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.38, $0.03 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $346.8 million versus the consensus estimate of $340.9 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
- Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
